Candid Therapeutics has filed a notice of an exempt offering of securities to raise $206,203,454.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Candid Therapeutics is raising up to $206,203,454.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Kenneth Song…